Surgery Partners Additional Paid-in Capital 2013-2026 | SGRY

Surgery Partners additional paid-in capital from 2013 to 2026. Additional paid-in capital can be defined as the excess over par value paid for common securities.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Surgery Partners Annual Additional Paid-in Capital
(Millions of US $)
2025 $2,541
2024 $2,521
2023 $2,498
2022 $2,478
2021 $1,622
2020 $608
2019 $663
2018 $674
2017 $696
2016 $321
2015 $316
2014 $58
2013 $60
2012 $0
Surgery Partners Quarterly Additional Paid-in Capital
(Millions of US $)
2026-03-31 $2,548
2025-12-31 $2,541
2025-09-30 $2,543
2025-06-30 $2,538
2025-03-31 $2,526
2024-12-31 $2,521
2024-09-30 $2,514
2024-06-30 $2,511
2024-03-31 $2,496
2023-12-31 $2,498
2023-09-30 $2,495
2023-06-30 $2,501
2023-03-31 $2,478
2022-12-31 $2,478
2022-09-30 $1,623
2022-06-30 $1,619
2022-03-31 $1,625
2021-12-31 $1,622
2021-09-30 $1,306
2021-06-30 $1,298
2021-03-31 $843
2020-12-31 $608
2020-09-30 $603
2020-06-30 $648
2020-03-31 $655
2019-12-31 $663
2019-09-30 $670
2019-06-30 $678
2019-03-31 $674
2018-12-31 $674
2018-09-30 $671
2018-06-30 $676
2018-03-31 $689
2017-12-31 $696
2017-09-30 $704
2017-06-30 $324
2017-03-31 $322
2016-12-31 $321
2016-09-30 $319
2016-06-30 $319
2016-03-31 $318
2015-12-31 $316
2015-09-30 $60
2015-06-30 $0
2015-03-31 $0
2014-12-31
2014-09-30 $0
2013-12-31 $60
2012-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $1.903B $3.309B
Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $129.251B 14.33
Danaher (DHR) United States $126.118B 22.33
Elevance Health (ELV) United States $85.740B 12.83
HCA Healthcare (HCA) United States $83.631B 13.02
Cencora (COR) United States $52.781B 16.27
Natera (NTRA) United States $32.768B 0.00
Labcorp Holdings (LH) United States $20.863B 15.10
Viatris (VTRS) United States $17.911B 6.28
DiDi Global (DIDIY) China $16.365B 25.64
EUROFINS SCIENT (ERFSF) Luxembourg $13.375B 0.00
BrightSpring Health Services (BTSG) United States $13.258B 54.19
Medpace Holdings (MEDP) United States $13.014B 28.64
Solventum (SOLV) United States $12.739B 11.79
Revvity (RVTY) United States $11.049B 19.34
ICON (ICLR) Ireland $10.775B 12.49
BioMerieux (BMXMF) France $9.232B 0.00
Charles River Laboratories (CRL) United States $8.745B 18.16
HealthEquity (HQY) United States $7.074B 23.57
Sonic Healthcare (SKHHY) Australia $6.895B 0.00
Avantor (AVTR) United States $6.384B 11.00
PACS (PACS) United States $5.978B 24.21
GETINGE (GNGBY) Sweden $5.438B 17.36
Bausch + Lomb (BLCO) Canada $5.331B 22.97
CochLear (CHEOY) Australia $5.195B 0.00
Caris Life Sciences,�Inc (CAI) United States $4.893B 0.00
Sotera Health (SHC) United States $4.489B 19.92
Alignment Healthcare (ALHC) United States $4.401B 236.56
Concentras Parent (CON) United States $3.646B 19.78
Organon (OGN) United States $3.519B 4.27
Establishment Labs Holdings (ESTA) United States $2.533B 0.00
Amplifon S.p.A (AMFPF) Italy $2.466B 13.19
Progyny (PGNY) United States $2.059B 34.13
Pediatrix Medical (MD) United States $1.932B 11.59
Agilon Health (AGL) United States $1.887B 0.00
Sonida Senior Living (SNDA) United States $1.732B 0.00
COMPASS Pathways (CMPS) United Kingdom $1.704B 0.00
GeneDx Holdings (WGS) United States $1.645B 65.20
Teladoc Health (TDOC) United States $1.368B 0.00
Ardent Health (ARDT) United States $1.294B 5.51
CareDx (CDNA) United States $1.294B 0.00
InnovAge Holding (INNV) United States $1.250B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.240B 0.00
Omada Health (OMDA) United States $1.069B 0.00
Nutex Health (NUTX) United States $1.033B 11.60
GoodRx Holdings (GDRX) United States $0.880B 16.06
CryoPort (CYRX) United States $0.744B 0.00
Enhabit (EHAB) United States $0.709B 25.89
Strata Critical Medical (SRTA) United States $0.498B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
Oncology Institute (TOI) United States $0.495B 0.00
Auna S.A (AUNA) Luxembourg $0.389B 4.74
Shoulder Innovations (SI) United States $0.369B 0.00
Forward Industries (FWDI) United States $0.319B 0.00
SBC Medicals (SBC) United States $0.303B 7.56
LifeMD (LFMD) United States $0.208B 0.00
Embecta (EMBC) United States $0.180B 1.17
Biodesix (BDSX) United States $0.180B 0.00
So-Young (SY) China $0.159B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
SkinHealth Systems (SKIN) United States $0.087B 0.00
QDM (QDMI) Hong Kong, SAR China $0.086B 14.28
Park Dental Partners (PARK) United States $0.082B 0.00
Sera Prognostics (SERA) United States $0.072B 0.00
DocGo (DCGO) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Lifeward (LFWD) United States $0.020B 0.00
IceCure Medical (ICCM) Israel $0.017B 0.00
Ainos (AIMD) United States $0.016B 0.00
OSR Holdings (OSRH) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Basel Medical Group (BMGL) Singapore $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Pomdoctor - (POM) China $0.011B 0.00
XWELL (XWEL) United States $0.010B 0.00
Aclarion (ACON) United States $0.007B 0.00
NewGenIvf Group (NIVF) Thailand $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Synergy CHC (SNYR) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00